MAM
BIIB icon

Mastrapasqua Asset Management’s Biogen BIIB Stock Holding History

Mastrapasqua Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17,015
Closed -$4.02M – 129
2019
Q1 		$4.02M Buy
17,015
+43
+0.3% +$13.5K 0.76% 49
2018
Q4 		$5.11M Sell
16,972
-1,272
-7% -$406K 1.14% 42
2018
Q3 		$6.45M Buy
+18,244
New +$6.28M 1.22% 37

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mastrapasqua Asset Management's BIIB Position: Q2 2019 in Review

Mastrapasqua Asset Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 17,015 shares — an estimated $4.02M sold.

Mastrapasqua Asset Management first reported a position in BIIB in Q3 2018 and held it in 3 quarters. The position peaked at $6.45M in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Mastrapasqua Asset Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Mastrapasqua Asset Management sold 17,015 Biogen shares in Q2 2019, an estimated $4.02M.
  • Mastrapasqua Asset Management first reported a position in Biogen in Q3 2018 and held it in 3 quarters.
  • Mastrapasqua Asset Management's Biogen position peaked at $6.45M in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Mastrapasqua Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.